ConductScience.org, home

Paper9028363

Glutathione S-transferase-pi expression and glutathione concentration in ovarian carcinoma before and after chemotherapy.

Cheng X and 6 others. Cancer, 1997. Cited by 55 papers, by iCite.

Cite this record

ConductScience Library. Glutathione S-transferase-pi expression and glutathione concentration in ovarian carcinoma before and after chemotherapy. Papers, record 9028363. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9028363

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Glutathione S-transferase-pi expression and glutathione concentration in ovarian carcinoma before and after chemotherapy.
PubMed
Journal
Cancer
PubMed
Year
1997
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
55
iCite
Relative citation ratio, by iCite
1.75
iCite
Revised in PubMed
2022-03-18
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cheng XX
2Kigawa JJ
3Minagawa YY
4Kanamori YY
5Itamochi HH
6Okada MM
7Terakawa NN

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Gene Expression Regulation, EnzymologicMajor topic
Gene Expression Regulation, NeoplasticMajor topic
GlutathioneMajor topic
Glutathione TransferaseMajor topic
Ovarian NeoplasmsMajor topic
Aged
Blotting, Western
Drug Resistance, Neoplasm
Female
Humans
Immunohistochemistry
Middle Aged
Time Factors

Source PubMed

Download CSV of topics

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 55 citations.

PMIDTitleJournalYearIn PapersSource
30038720
GSTP1 rs1695 is associated with both hematological toxicity and prognosis of ovarian cancer treated with paclitaxel plus carboplatin combination chemotherapy: a comprehensive analysis using targeted resequencing of 100 pharmacogenes.
Oncotarget2018https://conductscience.org/library/papers/30038720PubMed
29949936Glutathione in Ovarian Cancer: A Double-Edged Sword.Int J Mol Sci2018https://conductscience.org/library/papers/29949936PubMed
24238102Ets-1 regulates intracellular glutathione levels: key target for resistant ovarian cancer.Mol Cancer2013https://conductscience.org/library/papers/24238102PubMed
23595127Prognostic significance of several biomarkers in epithelial ovarian cancer: a meta-analysis of published studies.J Cancer Res Clin Oncol2013https://conductscience.org/library/papers/23595127PubMed
23105502Can serum Glutathione-S-transferase levels in carcinoma cervix be a predictor of radiation response?Indian J Clin Biochem2005https://conductscience.org/library/papers/23105502PubMed
22900535Glutathione levels in human tumors.Biomarkers2012https://conductscience.org/library/papers/22900535PubMed
21751272In vivo MR studies of glycine and glutathione metabolism in a rat mammary tumor.NMR Biomed2012https://conductscience.org/library/papers/21751272PubMed
20544021High-definition DNA methylation profiles from breast and ovarian carcinoma cell lines with differing doxorubicin resistance.PLoS One2010https://conductscience.org/library/papers/20544021PubMed
18185852Cisplatin nephrotoxicity: molecular mechanisms.Cancer Ther2003https://conductscience.org/library/papers/18185852PubMed
16231966Clinical pharmacokinetics of cyclophosphamide.Clin Pharmacokinet2005https://conductscience.org/library/papers/16231966PubMed
15132769Expression of the c-myc gene as a predictor of chemotherapy response and a prognostic factor in patients with ovarian cancer.Cancer Sci2004https://conductscience.org/library/papers/15132769PubMed
12079522Sensitivity to anticancer agents and resistance mechanisms in clear cell carcinoma of the ovary.Jpn J Cancer Res2002https://conductscience.org/library/papers/12079522PubMed
9569045Endogenous antioxidant enzymes and glutathione S-transferase in protection of mesothelioma cells against hydrogen peroxide and epirubicin toxicity.Br J Cancer1998https://conductscience.org/library/papers/9569045PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9028363

GET https://conductscience.org/api/papers/v1/9028363/authors